[1] Razali NN,Hwu TT,Thilakavathy.Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets[J].J Pediatr Endocrinol Metab,2015,28(9-10):1009-1017.
[2] Whyte MP,Schranck FW,Armamento-Villareal R.X-linked hypophosphatemia:a search for gender,race,anticipation,or parent of origin effects on disease expression in children[J].J Clin Endocrinol Metab,1996,81(11):4075-4080.
[3] 张偲,罗小平.低磷抗维生素D性佝偻病诊治进展[J].中国实用儿科杂志,2017,32(9):669-673.
[4] 李恬恬,张立琴.X-连锁低血磷性抗维生素D佝偻病基因突变研究进展[J].中国儿童保健杂志,2017,25(12):1233-1235.
[5] ivinjak M,Schnabel D,Staude H,et al.Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets:effects on linear growth and body disproportion[J].J Clin Endocrinol Metab,2011,96(12):e2097-e2105.
[6] Friedman NE,Lobaugh B,Drezner MK.Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia[J].J Clin Endocrinol Metab,1993,76(4):839-844.
[7] Linglart A,Biosse-Duplan M,Briot K,Chaussain C,et al.Therapeutic management of hypophosphatemic rickets from infancy to adulthood[J].Endocrine Connections,2014,3(1):13-30.
[8] Baroncelli GI,Bertelloni S,Ceccarelli C,et al.Effect of growth hormone treatment on final height,phosphate metabolism,and bone mineral density in children with X-linked hypophosphatemic rickets[J].J Pediatr,2001,138(2):236-243.
[9] Haffner D,Nissel R,Wuhl E,et al.Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets[J].Pediatrics,2004,113(6):e593-e596.
[10] Meyerhoff N,Haffner D,Staude H,et al.Effects of growth hormone treatment on adult height in severely short children with X-linked hypophophatemic rickets[J].Pediatr Nephrol,2018,33(3):447-456.
[11] Imel EA,Zhang X,Ruppe MD,et al.Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23[J].J Clin Endocrinol Metab,2015,100(7):2565-2573 |
